IONM Overview

Convertible Note Exchange Offer Update: Assure Holdings Corp. has amended its Convertible Note Exchange Offer, increasing the share consideration from 238.44 to 1,000 shares per $1,000 claim and extending the offer deadline to September 20, 2024.

Company Overview: Assure Holdings provides outsourced intraoperative neuromonitoring services, ensuring patient safety during surgeries by monitoring neural structures in real-time, and is accredited by The Joint Commission.

Exchange Offer Extension: Assure Holdings Corp. has extended the expiration date of its exchange offer for 9% Convertible Debentures from July 19, 2024, to July 26, 2024, with $2.7 million already tendered as of the previous deadline.

Company Overview: Assure Holdings provides outsourced intraoperative neuromonitoring and remote neurology services, ensuring patient safety during surgeries by employing trained technologists and physicians to monitor neural structures in real-time.

• Virpax Pharmaceuticals surged 139%.
• Kazia Therapeutics gained 129%.
• Longeveron Inc. surged 81.8%.
• VivoPower International climbed 56.8%.
• Various other companies experienced significant stock price movements.

• Lantheus Holdings rose 28.6%.
• SMART Global Holdings gained 17.4%.
• Hawaiian Electric Industries jumped 15.8%.

• Shineco, Inc. shares fell 40.1%.
• Zapp Electric Vehicles Group dropped 38.2%.
• LegalZoom.com, Inc. declined 25.7%.

• Analysts predict Apple to rally around 14%.

Helen of Troy Limited Earnings Report:

• Helen of Troy Limited (HELE) experienced a sharp decline in shares after reporting lower-than-expected first-quarter earnings and revising its FY25 guidance.
• Quarterly earnings were reported at 99 cents per share, missing the analyst consensus estimate of $1.59.
• Quarterly sales stood at $416.85 million, falling short of the analyst consensus estimate of $446.22 million.
• The stock price of Helen of Troy dropped by 30.3% to $62.06 following the news.

Stock Movements:

• Soligenix, Inc. (SNGX) saw a 195% increase in shares after announcing positive interim results for extended HyBryte treatment.
• uniQure N.V. (QURE) observed a 55.4% rise in shares due to updated interim data on AMT-130 for Huntington’s disease treatment.
• Various other companies like Pineapple Energy Inc., Anew Medical, Inc., Expensify, Inc., and more experienced significant stock movements, both positive and negative.